[1]
“In Silico Evaluation of Physalis angulata Secondary Metabolites as Potential QcrB Inhibitors in Mycobacterium tuberculosis and Mycobacterium bovis ”, JV, vol. 16, no. 1, pp. 24–34, May 2026, doi: 10.30742/b51bvx32.